Bionomics and Merck Enter New Research Collaboration

Bionomics Limited announces that it has entered into an exclusive Research Collaboration and License Agreement with Merck, known as MSD outside the United States and Canada, for its BNC375 research program targeting cognitive dysfunction associated with Alzheimer's disease and other central nervous system conditions.

http://ift.tt/1nxHedl